PDIA3 and breast carcinoma: Quantitative tandem-mass tag proteomics methodology was also used to identify proteins in the CM of MDA-MB-231 breast cancer cells that depend on PDIA3 activity, by comparison of proteins in the CM of control or 16F16-inhibited cells.